This paper thus provides reliable evidence of the relationship between LRG1 and TTR with the early stages of PDAC and the diagnostic performance of the panel in distinguishing PDAC from normal, benign disease states, and the patients with other cancers (colorectal, thyroid, and breast cancer, in particular). This evidence concerns the gene LRG1 and breast carcinoma.